Welcome to LookChem.com Sign In|Join Free

CAS

  • or

3393-64-4

Post Buying Request

3393-64-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

3393-64-4 Usage

Chemical Properties

CLEAR COLOURLESS LIQUID

Uses

Protonated diacetone alcohol and protonated 4- hydroxy-3-methyl-2-butanone undergo ?vinylation? and colli- sion-induced dehydration as the only primary reactions, the product of the former reaction consisting of up to 40% of the total product ion distribution.

Check Digit Verification of cas no

The CAS Registry Mumber 3393-64-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,3,9 and 3 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 3393-64:
(6*3)+(5*3)+(4*9)+(3*3)+(2*6)+(1*4)=94
94 % 10 = 4
So 3393-64-4 is a valid CAS Registry Number.
InChI:InChI=1/C5H10O2/c1-4(3-6)5(2)7/h4,6H,3H2,1-2H3/t4-/m1/s1

3393-64-4 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (H28483)  4-Hydroxy-3-methyl-2-butanone, tech 85%   

  • 3393-64-4

  • 250mg

  • 668.0CNY

  • Detail
  • Alfa Aesar

  • (H28483)  4-Hydroxy-3-methyl-2-butanone, tech 85%   

  • 3393-64-4

  • 1g

  • 1714.0CNY

  • Detail
  • Alfa Aesar

  • (H28483)  4-Hydroxy-3-methyl-2-butanone, tech 85%   

  • 3393-64-4

  • 5g

  • 5326.0CNY

  • Detail

3393-64-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-hydroxy-3-methylbutan-2-one

1.2 Other means of identification

Product number -
Other names 2-Butanone,4-hydroxy-3-methyl

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:3393-64-4 SDS

3393-64-4Relevant articles and documents

Chelation, activation, and proximity effects in the deprotection of dithianes with ZnBr2. Applications in the polyketide field

Vakalopoulos,Hoffmann

, p. 2185 - 2188 (2001)

(Matrix presented) Double deprotection of dithiane aldol equivalents is feasible under mild conditions with ZnBr2 and suitably placed MEM, BOM, and SEM groups which function as protecting, activating, and regiodirecting groups. The procedure is useful in natural product synthesis.

Method for preparing 3, 4-dimethylpyrazole and phosphate thereof

-

Paragraph 0096; 0098; 0099; 0107; 0115; 0123, (2019/04/17)

The invention discloses a method for preparing 3, 4-dimethylpyrazole and phosphate thereof. The method for preparing the 3, 4-dimethylpyrazole includes the steps: (1) feeding 2-butanone, aldehyde andalkali solution into a microchannel reactor and performing aldehyde ketone condensation reaction to produce 4-hydroxy-3-methyl-2-butanone salt; (2) mixing reaction liquid obtained in the step (1) andacid liquid in the microchannel reactor to obtain 4-hydroxy-3-methyl-2-butanone water solution; (3) performing reaction on hydrazine hydrate and the 4-hydroxy-3-methyl-2-butanone water solution in themicrochannel reactor, mixing reaction liquid with the alkali solution and hydrogen peroxide, and performing oxidative dehydrogenation reaction to obtain 3, 4-dimethylpyrazole water solution; (4) performing organic extraction and distillation on the 3, 4-dimethylpyrazole water solution to obtain the 3, 4-dimethylpyrazole. According to the method, reaction time is greatly shortened, the yield and the purity of products are ensured, and continuous production can be realized.

COMPOUND AND METHOD FOR THE TREATMENT OF PAIN

-

Page/Page column 9, (2011/10/12)

The disclosure herein provides a compound of formula 1. The disclosure also provides a method of synthesizing the compound of formula 1. The compound of formula 1 or its pharmaceutical acceptable salts, as well as polymorphs, solvates, and hydrates thereof may be formulated as pharmaceutical composition. The pharmaceutical composition of compound of formula 1 or the final compound may be formulated for non-invasive peroral, topical (example transdermal), enteral, transmucosal, targeted delivery, sustained release delivery, delayed release, pulsed release and parenteral methods. Such compositions may be used to treat chronic pain manifested with chronic diseases or its associated complications.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 3393-64-4